Evidence map›Paper›PMID 31717562›Full record

ArticleCells2019

MiR-21, MiR-29a, GATA4, and MEF2c Expression Changes in Endothelin-1 and Angiotensin II Cardiac Hypertrophy Stimulated Isl-1

Katrin Zlabinger, Andreas Spannbauer, Denise Traxler, Alfred Gugerell, Dominika Lukovic, Johannes Winkler, Julia Mester-Tonczar, Bruno Podesser, Mariann Gyöngyösi

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. miR-21 in Human Cardiomyopathies.Frontiers in cardiovascular medicine · 2021
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Katrin ZlabingerMedical University of Vienna, Department of Cardiology, 1090 Vienna, Austria.ORCID 0000-0002-3855-7643
Andreas SpannbauerMedical University of Vienna, Department of Cardiology, 1090 Vienna, Austria.ORCID 0000-0002-9819-0361
Denise TraxlerMedical University of Vienna, Department of Cardiology, 1090 Vienna, Austria.
Alfred GugerellMedical University of Vienna, Department of Cardiology, 1090 Vienna, Austria.ORCID 0000-0002-5178-9967
Dominika LukovicMedical University of Vienna, Department of Cardiology, 1090 Vienna, Austria.
Johannes WinklerMedical University of Vienna, Department of Cardiology, 1090 Vienna, Austria.
Julia Mester-TonczarMedical University of Vienna, Department of Cardiology, 1090 Vienna, Austria.
Bruno PodesserMedical University of Vienna, Department of Biomedical Research, 1090 Vienna, Austria.
Mariann GyöngyösiMedical University of Vienna, Department of Cardiology, 1090 Vienna, Austria.ORCID 0000-0002-7083-2107
Medical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cost- and time-intensive porcine translational disease models offer great opportunities to test drugs and therapies for pathological cardiac hypertrophy and can be supported by porcine cell culture models that provide further insights into basic disease mechanisms. Cardiac progenitor cells (CPCs) residing in the adult heart have been shown to differentiate in vitro into cardiomyocytes and could contribute to cardiac regeneration. Therefore, it is important to evaluate their changes on the cellular level caused by disease. We successfully isolated Isl1

Indexed as

BiomarkersDisease SusceptibilityAngiotensin IIAnimalsAntigens, SurfaceCardiomegalyCells, CulturedCellular ReprogrammingConnexin 43Endothelin-1GATA4 Transcription FactorGenetic Predisposition to DiseaseImmunophenotypingMEF2 Transcription FactorsMicroRNAsMyoblasts, CardiacAngiotensin IIAntigens, SurfaceBiomarkersConnexin 43Endothelin-1GATA4 Transcription FactorMEF2 Transcription FactorsMicroRNAsangiotensin IIcardiac hypertrophycardiac remodelingendothelin 1GATA4Isl-1MEF2cmiR-21miR29aporcine cardiac progenitor cells

Identifiers

PMID31717562
PMCPMC6912367
OpenAlexW2989503323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.